BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7616874)

  • 1. Formation of ethinylestradiol in postmenopausal women during continuous treatment with a combination of estradiol, estriol and norethisterone acetate.
    Klehr-Bathmann I; Kuhl H
    Maturitas; 1995 Apr; 21(3):245-50. PubMed ID: 7616874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.
    Kuhnz W; Heuner A; Hümpel M; Seifert W; Michaelis K
    Contraception; 1997 Dec; 56(6):379-85. PubMed ID: 9494772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Formation of Ethinylestradiol After Intramuscular Administration of Norethisterone Enantate.
    Friedrich C; Berse M; Klein S; Rohde B; Höchel J
    J Clin Pharmacol; 2018 Jun; 58(6):781-789. PubMed ID: 29522253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
    Al-Azzawi F; Wahab M; Sami S; Proudler AJ; Thompson J; Stevenson J
    Climacteric; 2004 Sep; 7(3):292-300. PubMed ID: 15669554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women.
    Stadberg E; Westlund P; Landgren BM; Aedo AR; Cekan SZ; Mattsson LA
    Maturitas; 1999 Sep; 33(1):59-69. PubMed ID: 10585174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study.
    Walker RJ; Lewis-Barned NJ; Sutherland WH; Goulding A; Edwards EA; de Jong SA; Gold E; Walker HL
    Menopause; 2001; 8(1):27-32. PubMed ID: 11201511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.
    Dören M; Schneider HP
    Maturitas; 1996 Oct; 25(2):99-105. PubMed ID: 8905600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
    Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
    Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women.
    Brynhildsen J; Hammar M
    Menopause; 2002; 9(2):137-44. PubMed ID: 11875333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen replacement in postmenopausal women: are we currently overdosing our patients?
    Tepper R; Goldberger S; Cohen I; Segal J; Yarkoni S; Fejgin M; Beyth Y
    Gynecol Obstet Invest; 1994; 38(2):113-16. PubMed ID: 7959337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women.
    Kaleli B; Yildirim B; Demir S; Alatas E
    Acta Obstet Gynecol Scand; 2003 Dec; 82(12):1107-11. PubMed ID: 14616255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatization and hydrolysis of norethisterone-3-oxime in rabbit.
    Li QG
    J Steroid Biochem Mol Biol; 1994 Jun; 49(2-3):227-31. PubMed ID: 8031720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of norethisterone acetate on urinary urodilatin excretion in postmenopausal women.
    Mueck AO; Seeger H; Armbruster FP; Lippert TH
    Clin Exp Obstet Gynecol; 1998; 25(3):76-8. PubMed ID: 9856301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of norethisterone acetate and estradiol on the serotonin metabolism of postmenopausal women.
    Mueck AO; Seeger H; Kasspohl-Butz S; Teichmann AT; Lippert TH
    Horm Metab Res; 1997 Feb; 29(2):80-3. PubMed ID: 9105905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a triphasic oestradiol/norethisterone acetate preparation with and without an oestriol component in the treatment of climacteric complaints.
    Hellberg D; Nilsson S
    Maturitas; 1984 Apr; 5(4):233-43. PubMed ID: 6429481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen.
    Nathorst-Böös J; Hammar M
    Maturitas; 1997 Jan; 26(1):15-20. PubMed ID: 9032742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.